Aurinia to Present at Bloom Burton & Co. Healthcare Conference
Aurinia Pharmaceuticals Inc., (NASDAQ:AUPH)(TSX:AUP) today announced that its Chief Executive Officer, Richard M. Glickman, will
present at the Bloom Burton & Co. Healthcare Conference in Toronto, Ontario on May 2, 2017 at 11:30pm ET. A webcast will be
available and can be accessed via the investor section of the Aurinia website, www.auriniapharma.com. A replay will also be archived on the site following the event.
About Aurinia
Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient
populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing
voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), an inflammation of the kidney caused by Systemic
Lupus Erythematosus (SLE) and represents a serious progression of SLE. The company is headquartered in Victoria, BC and focuses its
development efforts globally. www.auriniapharma.com.
We Seek Safe Harbor.
Aurinia Pharmaceuticals Inc.
Investor & Media Contact:
Celia Economides
Head of IR & Communications
ceconomides@auriniapharma.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170426005818/en/